917O DS-3939, a tumor-associated mucin 1 (TA-MUC1)–directed antibody–drug conjugate (ADC), in patients (pts) with advanced/metastatic (adv/met) solid tumors: Initial results from a first-in-human (FIH) study.
Saved in:
| Title: | 917O DS-3939, a tumor-associated mucin 1 (TA-MUC1)–directed antibody–drug conjugate (ADC), in patients (pts) with advanced/metastatic (adv/met) solid tumors: Initial results from a first-in-human (FIH) study. |
|---|---|
| Authors: | Patel, M.R.1 (AUTHOR), Doi, T.2 (AUTHOR), Yamamoto, N.3 (AUTHOR), Garrido-Laguna, I.4 (AUTHOR), Nishioka, S.5 (AUTHOR), Wu, S.6 (AUTHOR), Ostheimer, C.7 (AUTHOR), Nakajima, K.7 (AUTHOR), Carneiro, B.A.8 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS598-S598. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189419299 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 917O DS-3939, a tumor-associated mucin 1 (TA-MUC1)–directed antibody–drug conjugate (ADC), in patients (pts) with advanced/metastatic (adv/met) solid tumors: Initial results from a first-in-human (FIH) study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Patel%2C+M%2ER%2E%22">Patel, M.R.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Doi%2C+T%2E%22">Doi, T.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yamamoto%2C+N%2E%22">Yamamoto, N.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garrido-Laguna%2C+I%2E%22">Garrido-Laguna, I.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nishioka%2C+S%2E%22">Nishioka, S.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+S%2E%22">Wu, S.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ostheimer%2C+C%2E%22">Ostheimer, C.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nakajima%2C+K%2E%22">Nakajima, K.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Carneiro%2C+B%2EA%2E%22">Carneiro, B.A.</searchLink><relatesTo>8</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS598-S598. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189419299 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.1486 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S598 Titles: – TitleFull: 917O DS-3939, a tumor-associated mucin 1 (TA-MUC1)–directed antibody–drug conjugate (ADC), in patients (pts) with advanced/metastatic (adv/met) solid tumors: Initial results from a first-in-human (FIH) study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Patel, M.R. – PersonEntity: Name: NameFull: Doi, T. – PersonEntity: Name: NameFull: Yamamoto, N. – PersonEntity: Name: NameFull: Garrido-Laguna, I. – PersonEntity: Name: NameFull: Nishioka, S. – PersonEntity: Name: NameFull: Wu, S. – PersonEntity: Name: NameFull: Ostheimer, C. – PersonEntity: Name: NameFull: Nakajima, K. – PersonEntity: Name: NameFull: Carneiro, B.A. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
